본문으로 건너뛰기
← 뒤로

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer.

1/5 보강
European journal of medical research 📖 저널 OA 91.6% 2021: 1/1 OA 2022: 2/2 OA 2023: 5/5 OA 2024: 5/5 OA 2025: 88/88 OA 2026: 38/49 OA 2021~2026 2023 Vol.28(1) p. 475
Retraction 확인
출처

Xu X, Zhao J, Yang M, Han L, Yuan X, Chi W

📝 환자 설명용 한 줄

Thyroid cancer (TC) is the most predominant malignancy of the endocrine system, with steadily growing occurrence and morbidity worldwide.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Xu X, Zhao J, et al. (2023). The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer.. European journal of medical research, 28(1), 475. https://doi.org/10.1186/s40001-023-01382-2
MLA Xu X, et al.. "The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer.." European journal of medical research, vol. 28, no. 1, 2023, pp. 475.
PMID 37915103 ↗

Abstract

Thyroid cancer (TC) is the most predominant malignancy of the endocrine system, with steadily growing occurrence and morbidity worldwide. Although diagnostic and therapeutic methods have been rapidly developed in recent years, the underlying molecular mechanisms in the pathogenesis of TC remain enigmatic. The N6-methyladenosine(m6A) RNA modification is designed to impact RNA metabolism and further gene regulation. This process is intricately regulated by a variety of regulators, such as methylases and demethylases. Aberrant m6A regulators expression is related to the occurrence and development of TC and play an important role in drug resistance. This review comprehensively analyzes the effect of m6A methylation on TC progression and the potential clinical value of m6A regulators as prognostic markers and therapeutic targets in this disease.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기